Maxwell Biosciences
Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new CLAROMER® biotechnology platform to safely and permanently inactivate viruses, bacteria, fungi, and biofilms.
Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new CLAROMER® biotechnology platform to safely and permanently inactivate viruses, bacteria, fungi, and biofilms.